Literature DB >> 15936793

Role of clathrin-mediated endocytosis during vesicular stomatitis virus entry into host cells.

Xiangjie Sun1, Vivian K Yau, Benjamin J Briggs, Gary R Whittaker.   

Abstract

Vesicular stomatitis virus (VSV) is well established to enter cells by pH-dependent endocytosis, but mechanistic aspects of its internalization have remained unclear. Here, we examined the functional role of clathrin in VSV entry by expression of a dominant-negative mutant of Eps15 (GFP-Eps15Delta95/295), a protein essential for clathrin-mediated endocytosis. Whereas expression of GFP alone had no effect on VSV infection, expression of GFP-Eps15Delta95/295 severely limited infection. As independent ways to examine clathrin function, we also examined cells that had been treated with chlorpromazine and utilized small interfering RNA (siRNA) techniques. Inhibition of clathrin-mediated endocytosis by chlorpromazine treatment, as well as clathrin knock-down using siRNA duplexes directed against the clathrin heavy chain, also prevented VSV infection. In combination with previous morphological approaches, these experiments establish clathrin as an essential component needed for endocytosis of VSV.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15936793     DOI: 10.1016/j.virol.2005.05.006

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  122 in total

1.  Genetic inactivation of COPI coatomer separately inhibits vesicular stomatitis virus entry and gene expression.

Authors:  David K Cureton; Rebeca Burdeinick-Kerr; Sean P J Whelan
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

Review 2.  Advances in the field of lentivector-based transduction of T and B lymphocytes for gene therapy.

Authors:  Cecilia Frecha; Camille Lévy; François-Loïc Cosset; Els Verhoeyen
Journal:  Mol Ther       Date:  2010-08-24       Impact factor: 11.454

3.  Imaging multiple intermediates of single-virus membrane fusion mediated by distinct fusion proteins.

Authors:  Kye-Il Joo; April Tai; Chi-Lin Lee; Clement Wong; Pin Wang
Journal:  Microsc Res Tech       Date:  2010-09       Impact factor: 2.769

4.  RNAi screening reveals requirement for host cell secretory pathway in infection by diverse families of negative-strand RNA viruses.

Authors:  Debasis Panda; Anshuman Das; Phat X Dinh; Sakthivel Subramaniam; Debasis Nayak; Nicholas J Barrows; James L Pearson; Jesse Thompson; David L Kelly; Istvan Ladunga; Asit K Pattnaik
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

5.  Equine herpesvirus 1 enters cells by two different pathways, and infection requires the activation of the cellular kinase ROCK1.

Authors:  Arthur R Frampton; Donna B Stolz; Hiroaki Uchida; William F Goins; Justus B Cohen; Joseph C Glorioso
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

6.  Site-specific labeling of enveloped viruses with quantum dots for single virus tracking.

Authors:  Kye-Il Joo; Yuning Lei; Chi-Lin Lee; Jonathon Lo; Jiansong Xie; Sarah F Hamm-Alvarez; Pin Wang
Journal:  ACS Nano       Date:  2008-08       Impact factor: 15.881

7.  Dissecting the role of COPI complexes in influenza virus infection.

Authors:  Eileen Sun; Jiang He; Xiaowei Zhuang
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

8.  LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus.

Authors:  Danit Finkelshtein; Ariel Werman; Daniela Novick; Sara Barak; Menachem Rubinstein
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-15       Impact factor: 11.205

9.  Glycoprotein-dependent acidification of vesicular stomatitis virus enhances release of matrix protein.

Authors:  Chad E Mire; Derek Dube; Sue E Delos; Judith M White; Michael A Whitt
Journal:  J Virol       Date:  2009-09-23       Impact factor: 5.103

10.  West Nile virus entry requires cholesterol-rich membrane microdomains and is independent of alphavbeta3 integrin.

Authors:  Guruprasad R Medigeshi; Alec J Hirsch; Daniel N Streblow; Janko Nikolich-Zugich; Jay A Nelson
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.